Kane Biotech Financials

Kane Biotech Stock Summary

Kane Biotech competes with Biovaxys Technology. Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. Kane Biotech is traded on OTC Exchange in the United States.

Kane Biotech Key Financial Ratios

There are many critical financial ratios that Kane Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Kane Biotech reports annually and quarterly.

Kane Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kane Biotech's current stock value. Our valuation model uses many indicators to compare Kane Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kane Biotech competition to find correlations between indicators driving Kane Biotech's intrinsic value. More Info.Kane Biotech is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kane Biotech's earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of Kane Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kane Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kane Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Kane Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kane Biotech's daily price indicators and compare them against related drivers.

When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.